Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ANI Pharmaceuticals Inc (NASDAQ:ANIP)

63.17
Delayed Data
As of 3:59pm ET
 +0.30 / +0.48%
Today’s Change
26.80
Today|||52-Week Range
70.92
+39.99%
Year-to-Date
Mallinckrodt DMD Drug Gets Fast Track Status in the U.S.
10:28am / Zacks.com - Paid Partner Content
Urban Outfitters, Fogo de Chao, Oclaro, ANI Pharmaceuticals and FormFactor highlighte...
Aug 24 / Zacks.com - Paid Partner Content
Vanda Stock Up on Favorable U.S. Court Ruling for Fanapt
9:39am / Zacks.com - Paid Partner Content
Mylan (MYL) Draws Flak for Over Pricing EpiPen, Stock Down
Aug 24 / Zacks.com - Paid Partner Content
Amgen Gets CRL for Secondary Hyperparathyroidism Drug
Aug 25 / Zacks.com - Paid Partner Content
Pfizer to Acquire Rights to AstraZeneca's Antibiotics Business
Aug 24 / Zacks.com - Paid Partner Content
Mylan (MYL) Obtains Favorable USPTO Ruling for Copaxone
Aug 25 / Zacks.com - Paid Partner Content
Clovis (CLVS) Stock Up on FDA Priority Review for Rucaparib
Aug 24 / Zacks.com - Paid Partner Content
Kindred Biosciences (KIN) Jumps: Stock Moves 5.7% Higher
Aug 25 / Zacks.com - Paid Partner Content
3 Small-Cap Stocks With Sky-High Growth Potential
Aug 23 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close62.87
Today’s open62.89
Day’s range62.32 - 64.32
Volume147,295
Average volume (3 months)225,662
Market cap$723.9M
Dividend yield--
Data as of 3:59pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)-49.03%
Earnings growth (this year)+51.29%
Earnings growth (next 5 years)+15.40%
Revenue growth (last year)+36.36%
P/E ratio74.3
Price/Sales6.83
Price/Book4.52

Competitors

 Today’s
change
Today’s
% change
BPMCBlueprint Medicines ...+0.81+2.98%
NTLAIntellia Therapeutic...-0.23-1.09%
EDITEditas Medicine Inc-0.02-0.11%
INOInovio Pharmaceutica...+0.19+2.19%
Data as of 4:00pm ET, 08/26/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)$1.09
Annual revenue (last year)$76.3M
Annual profit (last year)$15.3M
Net profit margin20.03%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Arthur S. Przybyl
Vice President-
Operations
James G. Marken
Corporate headquarters
Baudette, Minnesota

Forecasts

Partner Offers

Search for Jobs